A sunny day is unfolding here on the Pharmalot corporate campus, where the mascots are happily frollicking among the weeds. As for us, we are brewing the mandatory cup of stimulation. What about you? Heading off toward your own campus? Prepping for those meetings and deadlines? Whatever you encounter, we hope your day goes well. One housekeeping note: we will break early today to shuffle one of the short people off to an institution of higher learning. See you soon...
Advanced Melanoma Treatment Shrinks Tumors: Study (Reuters)
Cephalon CEO Takes A Medical Leave Of Absence (Bloomberg News)
Drugmakers Experiment With Design (The Financial Times)
Celgene Has Been Plotting Revlimid Challenge (The Wall Street Journal)
CVS/Caremark Closes Mail-Order Facility And Cuts 400 Jobs (The Birmingham News)
Statins Do Not Cause Cancer: Study (MedPage Today)
UK's NICE Wants Evidence For Avastin & Bowel Cancer (The Telegraph)
Pfizer Continues To Have Economic Impact On Michigan (MLive)
UK's NICE Rejects Gleevec For Stomach Cancer Recurrence (PharmaTimes)
1 Comment
Ed, hope that you're not headed off to Faber College (i.e., pictorial insert from "Animal House"), where "Knowledge is Good", but if you're not careful, it could be, in the words of John Blutarski "seven years of college down the drain".
Good luck.